Commentary on: Is It Worth Using Botulinum Toxin Injections for the Management of Mild to Moderate Blepharoptosis?

Aesthet Surg J. 2022 Dec 14;42(12):1382-1384. doi: 10.1093/asj/sjac161.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blepharoptosis* / drug therapy
  • Botulinum Toxins, Type A* / administration & dosage
  • Botulinum Toxins, Type A* / adverse effects
  • Humans

Substances

  • Botulinum Toxins, Type A